| License: Creative Commons Attribution Non-commercial 4.0 PDF - Published Version (15MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-445317
- DOI to cite this document:
- 10.5283/epub.44531
Abstract
Head and neck squamous cell carcinoma (HNSCC) is an aggressive and difficult‐to‐treat cancer entity. Current therapies ultimately aim to activate the mitochondria‐controlled (intrinsic) apoptosis pathway, but complex alterations in intracellular signaling cascades and the extracellular microenvironment hamper treatment response. On the one hand, proteins of the BCL‐2 family set the threshold for ...

Owner only: item control page